Medicines (MDCO): Today's Featured Health Care Winner

Medicines ( MDCO) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 2%. By the end of trading, Medicines rose 23 cents (1.1%) to $21.33 on average volume. Throughout the day, 515,116 shares of Medicines exchanged hands as compared to its average daily volume of 399,700 shares. The stock ranged in a price between $21.12-$21.90 after having opened the day at $21.13 as compared to the previous trading day's close of $21.10. Other companies within the Health Care sector that increased today were: Galena Biopharma ( GALE), up 28%, EntreMed ( ENMD), up 13.1%, Biodel ( BIOD), up 11.4%, and Stereotaxis ( STXS), up 7.4%.

The Medicines Company, a pharmaceutical company, provides various medicines to hospitals for advancing the treatment of critical care patients worldwide. Medicines has a market cap of $1.17 billion and is part of the drugs industry. The company has a P/E ratio of 10.4, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 13.4% year to date as of the close of trading on Wednesday. Currently there are four analysts that rate Medicines a buy, no analysts rate it a sell, and two rate it a hold.

TheStreet Ratings rates Medicines as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Rosetta Genomics ( ROSG), down 20.8%, Escalon Medical Corporation ( ESMC), down 20.7%, Dynacq Healthcare ( DYII), down 17.1%, and IsoRay ( ISR), down 15.9%, were all losers within the health care sector with Eli Lilly and Company ( LLY) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)

Otonomy Shares Fall On Disappointing Phase 3 Data - Biotech Movers

Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite

How to Trade the Week's Most Active Stocks--Rite Aid, Amgen, MuleSoft and More

AveXis, Esperion and Amgen Among Biotech Movers